B.1.1.529 variant named Omicron, designated as a Variant of concern (VOC) by WHO

WHO’s Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) was convened on 26th November 2021 to assess the variant B.1.1.529. Based on the available evidences, the group of experts has advised WHO that this variant should be designated as a Variant of concern (VOC), and named Omicron. 

The B.1.1.529 variant was first reported to WHO from South Africa on 24th November 2021. The first known confirmed B.1.1.529 infection was from a specimen collected on 9th November 2021. Since then, the number of COVID-19 cases has steeply increased in almost all provinces in South Africa. This variant is characterised by a large number of mutations. Apparently, there is an increased risk of reinfection with this variant, as compared to others.  

Hence, based on the available evidences, the expert group has advised WHO that this variant should be designated as a VOC, and named Omicron. 

A variant of concern (VOC) is a variant of interest (VOI) that has shown an increase in transmissibility and/or virulence and/or decrease in effectiveness of public health measures at a degree of global public health significance: 

Individuals are reminded to take appropriate COVID-19 measures to reduce their risk of disease, including proven public health and social measures such as wearing well-fitting masks, hand hygiene, physical distancing, improving ventilation of indoor spaces, avoiding crowded spaces, and getting vaccinated. 

 *** 

Source:  

WHO 2021. News – Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. Published 26 November 2021. Available online at https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern  

Latest

Outbreak of Bundibugyo Ebolavirus in DR Congo and Uganda

The current orthoebolavirus outbreak in Democratic Republic of Congo...

Neanderthals Performed Dental Caries Interventions 59,000 Years Ago

Prehistoric dentistry is far older than 14,000 years as...

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Newsletter

Don't miss

Delivering Oral Dose of Insulin to Patients of Type 1 Diabetes: Trial Successful in Pigs

A new pill has been designed which delivers insulin...

A Novel Method for Real Time Detection of Protein Expression 

Protein expression refers to the synthesis of proteins within...

Iboxamycin (IBX): a Synthetic Broad-Spectrum Antibiotic to address Anti-Microbial Resistance (AMR)

Development of multi-drug resistance (MDR) bacteria in the past...

New insights into Marine Microplastic Pollution 

Analysis of data obtained from marine water samples collected...

Soberana 02 and Abdala: World’s first Protein conjugate Vaccines against COVID-19

The technology used by Cuba to develop protein-based vaccines...

A New Shape Discovered: Scutoid

A new geometrical shape has been discovered which enables...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Outbreak of Bundibugyo Ebolavirus in DR Congo and Uganda

The current orthoebolavirus outbreak in Democratic Republic of Congo (DRC) and Uganda is confirmed to be caused by the species Orthoebolavirus bundibugyoense (Bundibugyo virus),...

Neanderthals Performed Dental Caries Interventions 59,000 Years Ago

Prehistoric dentistry is far older than 14,000 years as indicated by Villabruna specimen from Late Upper Palaeolithic era. A recent study on 59,000-year-old Neanderthal...

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...